Company intelligence / Profile preview

NeoMend

Irvine, California, United States

Ownership: Private
Development stage: Other

Overview

Progel Air Leak Sealant is FDA-approved for intraoperative sealing of air leaks post-lung resection, reducing post-operative air leaks and hospital stay; has CE mark for lung sealing and anti-adhesion

Therapeutic areas: PulmonologyOther
Modalities: Hydrogel-based drug delivery therapyDevice
Industry: Surgical Medical Devices

Partnerships

Novozymes Biopharma (supplier of albucult)

Beyond the preview

Go deeper on NeoMend.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NeoMend.

Explore the full profile